Quicker lab reports saves costs
Beckman Coulter developed a new integrated lab systems: The UniCel DxC880i prototype should deliver efficient disease management services.
Laboratory
New Cancer Drug Hope
AstraZeneca has been collaborating with researchers who detected a potential Aurora B inhibitor.
Electro-medical safety tester meets new IEC 62353 standard
Rigel Medical, part of the Seaward Group, has launched a new biomedical electrical safety analyser.
Ever expanding rapid diagnostic products
Inverness Medical Innovations develops and manufactures rapid diagnostic products for use in preventive as well as interventional therapies.
Blood test may detect Alzheimer's disease before symptoms appear
A new blood test is under development that has detected two kinds of proteins found in people suffering Alzheimer's.
Community acquired pneumonia
Community-acquired pneumonia (CAP) is a major health problem globally. A new test now quickly identify pathogens. BinaxNOW tests quickly identify pathogens
ITALY
Bologna - The University Hospital S.Orsola-Malpighi has 1,800 beds and is one of the largest to install the DNLab management system. With 150 workstations connected to the LIS and over 50 analysers, each day, the two laboratories (central and microbiology) receive almost 3,000 orders and carry out over nine million tests annually. Hospital wards and departments are connected via Web to the LIS…
Integration in 3 stages
Hospitals increasingly co-operate with other establishments, and networking is becoming a way of life. Such change is also occurring in many hospital laboratories. By co-operating with other hospital labs and laboratory institutes, hospital labs try to improve their financial situation. By Dr Burkhard Ziebolz of Roche Diagnostics GmbH
EU challenge to worldwide BRCA2 gene patent
An unparalleled legal challenge has been underway in the EU regarding the number of human gene patents held by US-based corporation Myriad Genetics.
Test identifies patients who benefit from targeted cancer drugs
USA - A new laboratory test - EGFRx, developed by the Weisenthal Cancer Group* - has accurately identified patients who would benefit from treatment with the molecularly-targeted anti-cancer therapies gefitinib (Iressa, AstraZeneca) and erlotinib (Tarceva, Genentech), according to clinical data published at the annual meeting of the American Society of Clinical Oncology (ASCO).
New Microarray technology to check bird 'flu
USA - A new technology, named glycan microarray, can identify pathogens in a few hours and give advance warning of the ability of a virus to infect humans.
Biochip for the early detection of cancer
The Innsbruck Biocentre, led by Professor Lukas Huber, is involved in a major European research project. This involves the development of a 'biological interface' for a new semiconductor developed by Siemens.
Health Optimum
Downloading digitally signed clinical test results from home is possible and 40% of users residing in the Treviso region in Veneto, do so regularly.
Near-patient testing (NPT)
Near-patient testing (NPT) is any analytical process performed for, or by, a patient outside the traditional clinical laboratory. By Manole Cojocaru MD PhD, scientific consultant at ROMAR Medical-Laboratory Colentina, Bucharest
Advances in analytical and diagnostic tests
The development of diagnostic products and systems has paralleled the development of new technologies in fields such as biology, electronics and computer science.
Analytica 25-28 April 2006
Red green and white biotechnology
Asylum seekers and healthcare
UK - Over 100,000 asylum seekers have been relocated throughout London and England's southeast, to spread the cost of their medical care.
Tuberculosis blood test gains EU approval
TB causes three million deaths annually, ranking it higher than any other infectious disease. And TB has resurged in Europe. In August, the British Thoracic Society, British Lung Foundation and TB Alert highlighted its increase in over the last 15 years in the UK alone.
Award for HIV monitoring
The CyFlow and CyLab technique (e.g. for economical CD4/CD8 counting in HIV monitoring in developing countries) has received 1st prize in the Innovations Award 2003, given by the State Ministry of Economy, Dresden, Germany.
Biochips
Due to economic pressure, laboratories increasingly consolidate and automate procedures. Further cost reductions could come about through miniaturisation and multi-parameter tests.
Web advisories aid physicians
Monitoring and rapidly introducing new developments into everyday practice is an increasingly difficult task for many doctors. Additionally, patients are more informed due to media medical reports, which raise their expectations that doctors can offer a quick, reliable interpretation of the latest medical data.
Advances in blood group serology
Todays test formats (gel technology, micro test plates), plus laboratory electronic data processing and automation, have changed the classic format of blood group serological examinations significantly - and reduced the danger of life-threatening errors.
Article • Stick to conventional tests!
New cervical smear tests are not better
France - Researchers have found new cervical smear tests to be unreliable and conclude that these should not replace conventional tests (PAP smears). Their study also emphasises the need to improve the 'hard evidence' in studies of new technologies. It also has implications for the regulation of medical devices and clinical practice, as well as hospital laboratory economics.